A Diuretic Response is Associated with the Early Prognosis of Patients Undergoing Repeat Tricuspid Valve Surgery Due to Severe Tricuspid Regurgitation After Left-Sided Valvular Surgery
DOI:
https://doi.org/10.1532/hsf.4829Keywords:
repeat cardiac surgery, severe tricuspid regurgitation, critical cardiac surgery, risk factorsAbstract
Objective: To analyze the factors affecting the early prognosis of patients undergoing repeat tricuspid valve surgery due to severe tricuspid regurgitation after left-sided valvular surgery.
Method: We retrospectively analyzed 76 patients undergoing repeat tricuspid valve surgery due to severe tricuspid regurgitation after left-sided valvular surgery at Peking University International Hospital between October 2017 and February 2021. Patients were divided into two groups, according to preoperative weight control and whether the adjusted diuretic dose exceeded 40 mg of furosemide (or the equivalent dose). The factors affecting the early prognosis were analyzed through postoperative follow up.
Results: Thirty-five male patients (46.1%), aged 57±13 years, were enrolled in the study. For the patients who received a preoperative same dose of furosemide ≥40 mg/day and a same dose of furosemide <40 mg/day, the baseline data basically were the same. There were 76 patients (100%) who were followed up. Endpoint events during the follow up were as follows: Six patients (7.9%) died, two patients (2.6%) were admitted to the hospital or transferred to the intensive care unit due to cardiac insufficiency, and other conditions such as severe tricuspid regurgitation on repeat ultrasound, bilateral lower extremity edema, and inability to reduce or stop diuretics were found in five cases (6.6%). Compared with the group with the same dose of furosemide <40 mg/day group, the ≥40 mg/day group had a higher incidence of endpoints (12, 27.3% vs. 1, 3.1%, P = 0.006).
Conclusion: In patients undergoing repeat tricuspid valve surgery due to severe tricuspid regurgitation after left-sided valvular surgery, a diuretic response was associated with surgical prognosis. Compared with the low-dose furosemide group, the high-dose group (≥40 mg/) had a significantly increased incidence of early events.
References
Kennelly P, Sapkota R, Azhar M, Cheema FH, Conway C, Hameed A. 2021. Diuretic therapy in congestive heart failure. Acta Cardiol. 1-8.
Kristjansdottir I, Thorvaldsen T, Lund LH. 2020. Congestion and Diuretic Resistance in Acute or Worsening Heart Failure. Card Fail Rev. 6:e25.
Kwon DA, Park JS, Chang HJ, et al. 2006. Prediction of outcome in patients undergoing surgery for severe tricuspid regurgitation following mitral valve surgery and role of tricuspid annular systolic velocity. Am J Cardiol. 98:659-61.
LaPar DJ, Likosky DS, Zhang M, et al. 2018. Development of a Risk Prediction Model and Clinical Risk Score for Isolated Tricuspid Valve Surgery. Ann Thorac Surg. 106:129-136.
Mao B, Sun L, Zhang J, Zhou M, Zhang F. 2016. Perioperative factors associated with short- and long-term outcomes after tricuspid valve replacement. Interact Cardiovasc Thorac Surg. 23:845-850.
ter Maaten JM, Dunning AM, Valente MA, et al. 2015. Diuretic response in acute heart failure-an analysis from ASCEND-HF. Am Heart J. 170:313-21.
Testani JM, Brisco MA, Turner JM, et al. 2014. Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure. Circ Heart Fail. 7:261-70.
Valente MA, Voors AA, Damman K, et al. 2014. Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J. 35:1284-93.
Voors AA, Davison BA, Teerlink JR, et al. 2014. Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF. Eur J Heart Fail. 16:1230-40.
Writing Committee M, Otto CM, Nishimura RA, et al. 2021. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 77:450-500.
